Marapharm Ventures Inc. Provides Update on Critical to Security Inspection
KELOWNA, BC, May 14, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") We are pleased to announce that the fiber optic cable inspection to service our site in the North Las Vegas Apex Business Park is now complete. This initiative brings high-speed online benefits to the entire business park and will support our current demand and our long-term objectives meeting the requirements for our future infrastructure.
CenturyLink, the third-largest telecommunications company in the United States, completed the network architecture and worked closely with our sub-contractors to ensure the installation passed mandrel testing.
This utility is a critical state requirement to pass the final inspection and meet compliance to operate a cannabis facility in Nevada. The City of North Las Vegas Police Department must have the ability to monitor the interior and exterior of a cannabis establishment, by "live feed" video surveillance which must be accessible at all times, and in real-time. Time also must be measured in accordance with the U.S. National Institute Standards and Technology standards and all recorded images must be retrievable for a minimum of 60 days.
Marapharm deployed both dome and bullet cameras with a host of built-in "smart" features, some of which include, motion, line crossing, intrusion detection, motorized zoom lens, enhanced image features and built-in infra-red LED effective up to 98 feet. These products are integrated with our security control system and can be accessed remotely. We look forward to going "live".
The Las Vegas Review-Journal, featuring an artist rendering of our flagship facility, reported on our future development and expanded on cannabis businesses in Southern Nevada, April 30, 2018. Visit https://www.reviewjournal.com/homes/resale-news/marijuana-based-businesses-continue-development/
"We would like to thank the very good folks at KLA Laboratories Inc., and CenturyLink for their outstanding partnership and professional advisement to ensure that we have met or exceeded all state regulations in every aspect". Corey Klassen, VP of Corporate Development
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
SOCIAL MEDIA:
Facebook: facebook.com/marapharm
Twitter: twitter.com/marapharm
Web Program: marapharm.tv
STOCK EXCHANGES:
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm's ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD - LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions are intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward- looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.
SOURCE Marapharm Ventures Inc.
![](https://rt.newswire.ca/rt.gif?NewsItemId=C8890&Transmission_Id=201805140807CANADANWCANADAPR_C8890&DateId=20180514)
www.marapharm.com or Linda Sampson, CEO 778-583-4476, email [email protected]
Share this article